BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 1, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Dec. 16, 2009

View Archived Issues

Panel recommends RCTs for prostate cancer treatments

GAITHERSBURG, Maryland – As some device makers tell it, enrolling patients into a randomized clinical trial (RCT) is like getting dancers on the dance floor, at least in one respect; it's tough to get someone to be the first. Unlike the accumulation of dancers on the dance floor, however, the arrival of the first enrollee in an RCT does not ensure a landslide of participation. (Medical Device Daily) Read More

ConforMIS launches next generation iUni G2 device

Read More

Report from Europe: Alcon bolsters ophthalmology segment with Optonol purchase

Read More

Court report: Luna settles with Hansen, gives up stock, $5M promissory note

Read More

Deals roundup: Covidien says $58.7M tender offer accepted by Aspect

Read More

Coming Wednesday in MDD Perspectives: The "war" on Christmas: Three lessons, no carols

Read More

Financings roundup: SBi secures $30M credit facility, funds support new products

Read More

Agreements/contracts: Corgenix, BG Medicine form supply agreement

Read More

Patent watch: Sword Diagnostics secures Raman Scattering test tech

Read More

Med-Tech Notes

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Cardio Extra

Read More

New blood test may detect early-stage colon cancer

Medical researchers with EDP Biotech (Knoxville, Tennessee) say they have captured national attention with a new technology for a simple blood test designed to detect early-stage colon cancer. (Medical Device Daily) Read More

Myomo restores function in stroke patient victims

Read More

Report from Europe: Ability of cardiopoietic cells to restore cardiac function evaluated

Read More

Washington roundup: Device tax would be delayed under new Senate amendment

Read More

Deals roundup: Abbott to acquire Starlims Technologies for $123M in cash

Read More

Today's MDD food for med-tech thought

Read More

Agreements/contracts: HealthEdge partners with iWay to integrate HealthRules

Read More

Patent watch: ATS Medical gains tech to cut tissue materials for devices

Read More

Financings roundup: PatientKeeper raises $13M to help attain 'meaningful use'

Read More

Court report: 30 indicted for $61 million in fraudulent Medicare billings

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Oncology Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 31, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing